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Abstract
Introduction: Lung cancer is the leading cause of death among the cancers seen in the United
States. Hypercalcemia and leukocytosis are two common paraneoplastic syndromes associated
with lung cancer. Unfortunately patients presenting with Hypercalcemia- leukocytosis syndrome
has a worse prognosis than patients presenting with lung cancer alone.
Case presentation: We present a 67 yr old Caucasian male with a history of active smoking
presenting as pneumonia being diagnosed as cavitating squamous cell carcinoma of the lung with
hypercalcemia-leukocytosis syndrome
Conclusion: There should be a high degree of suspicion to diagnose lung cancer in patients
presenting with symptoms of paraneoplastic syndrome.
Introduction
Malignant neoplasms remain the second most common
cause of death in the United States, and out of these neo-
plasms lung cancer is the leading cause of mortality.[1]
Paraneoplastic neurologic syndromes (PNS) is a rare
group of disorders associated with lung cancer and
believed to be due to autoimmunity against normal neu-
ronal tissue as a result of similar neuronal antigens
expressed by tumor cells. Unfortunately there is no cost
effective screening method to detect lung cancer but if
patients presents with features of PNS, early detection and
treatment of the underlying tumor offers the best chance
of treatment [2]
Case report
A 67 year old Caucasian male presented to the emergency
department with complaints of high grade fever, cough
with yellowish phlegm for the past three days. He also had
exertional dyspnea New York Heart Association (NYHA
grade 3), which was attributed to his heart failure from
under lying ischemic heart disease. The dyspnea had wors-
ened from Grade 2 to Grade 3 over the past 5–6 months.
There was no chest pain.
He had a history of atherosclerotic heart disease status
post coronary artery bypass graft done three years ago and
congestive heart failure (CHF), Diabetes Mellitus type II
and hypertension for the past 15 years. He smoked a pack
of cigarettes every day for thirty years. He was on aspirin,
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carvedilol, lisinopril, atorvastatin, furosemide and glipiz-
ide.
On examination, the patient was in no apparent distress.
He was icteric, not cyanosed, no clubbing, no palpable
lymph nodes, poor peripheral pulses and bilateral pedal
edema. Jugular venous distension of 3–4 cm was noted.
Auscultation of the lungs revealed decreased air entry in
right lower zone and bibasilar rales. A systolic ejection
murmur grade 2/6 was heard in the aortic area. Abdomen
was soft with a 2 finger breadth enlargement of the liver.
Rest of the examination was normal.
Complete blood count showed leukocytosis with pre-
dominant neutrophils and a left shift. Hemoglobin-
hematocrit and platelet count was normal. The patient
had slight hyponatremia (132 meq), hypercalcemia 13.5
mg/dl, while other serum electrolytes were within normal
range. He had a raised total bilirubin (5.3 mg/dl) while
other liver function tests were normal.
Chest X-ray showed bilateral pleural effusion, right lower
lung field infiltrate, cardiomegaly and chronic interstitial
lung changes. The impression was right lower lobe pneu-
monia (figure 1). An EKG demonstrated sinus rhythm
with q waves in leads II, II, aVF and V1-V5 suggestive of
old infarct.
A presumptive diagnosis of pneumonia was made and he
was started on intravenous ciprofloxacin, Piperacillin/
Tazobactam. The increase in bilirubin was speculated to
be secondary to congestion of the liver due to CHF and he
was treated with furosemide, digoxin, and captopril.
Chest CT without contrast showed a mixed density pleural
based lesion in the right lower lobe measuring 7 cm (SI)
× 5.4 cm (AP) × 7.9 cm (TV) for which a diagnostic con-
sideration of cavitating neoplasm, infectious lesion and
sequestration was entertained (Figure 2) There was no evi-
dence of mediastinal, axillary or hilar adenopathy.
Abdominal CT without contrast showed a large amount of
intraperitoneal ascites present within abdomen and pel-
vis. The liver demonstrated a nodular contour suggestive
of cirrhotic morphology. Multiple bilobed low attenua-
tion lesions with a peripheral rim enhancement of varying
sizes suggestive of metastases versus septic emboli were
seen (Figure 3). A soft tissue mass adjacent to the posterior
segment of the right lobe of the liver which could repre-
sent an exophytic liver lesion versus a mesenteric soft tis-
sue mass was seen. A CT scan with contrast was suggested
but the patient refused due to previous contrast allergy.
Fiberoptic bronchoscopy was done on the 5th days after
admission and patient tolerated the procedure well. No
endobronchial lesions were seen. Bronchial lavage, aspi-
rate and brushings from the right lower lobe were done
and 20 cc of hemorrhagic fluid was sent for analysis which
showed few atypical squamous cells, mixed respiratory
flora, no acid fast bacilli, no growth on culture. A trans-
bronchial biopsy of the right lower lobe was done and the
biopsy specimen consisted of several tan grey soft tissues
measuring 1.2 × 0.2 × 0.1 cm. The biopsies showed essen-
tial bronchial mucosa with respiratory epithelium and
foci of squamous metaplasia with acute inflammation.
CXR with right lower lobe infiltrate Figure 1
CXR with right lower lobe infiltrate.
CT chest shows pleural based lesion in the right lower lobe  measuring 7 cm (SI) × 5.4 cm (AP) × 7.9 cm (TV) Figure 2
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Since fiberoptic bronchoscopy was inconclusive a CT
guided transthoracic needle biopsy was done which yield
50 cc of yellow brown purulent material was aspirated
from posterior pleural based collection in the right lower
lobe at the same time due the questionable.
The purulent material obtained on CT guided biopsy of
the lung revealed squamous cell carcinoma with extensive
coagulation necrosis. There was no evidence of infection.
Hence, all antibiotics were discontinued and oncology
consult was obtained. CT guided needle core biopsy of the
liver was negative for malignancy and showed mild
inflammatory changes. Whole body PET scan was done to
detect secondaries, but showed degenerative arthritic
changes in knees and feet and no other focal changes that
would suggest metastases. The patient had a persistent ele-
vated leukocyte count with an elevated polymorphonu-
clear cell count and elevated calcium levels. The patient
was offered sugary but the patient and the family refused
surgery as the patients had moderate to high risk mortality
from the surgery due to his multiple medical problems.
The patient's poor prognosis was discussed with him and
was placed in hospice care.
Discussion
Malignant neoplasms remain the second most common
cause of death in the United States, and lung cancer kills
more than any other type of cancer including breast can-
cer, prostate cancer and colon cancer combined [1] The
chest X-ray and CT scan can be used to diagnose lung can-
cer as in our patient but at a later stage. This delays the
diagnosis leading to a guarded prognosis due to advanced
disease process [3]
Can these cancers be diagnosed at an early stage? Potential
molecular biomarkers for squamous cell carcinomas have
been identified and need to be validated in their use in sig-
nificantly reducing the lead time for diagnosis [4]
PNS are caused by the distal effects of the cancer but not
due to invasion, metastases, infection, ischemia, meta-
bolic and nutritional deficits, surgery, or other forms of
tumor treatment. [5] The incidence of PNS for solid
tumors is < 1%. [6] These syndromes are not frequent or
pathognomonic for a signal definitive diagnosis thus
there should be a high degree of clinic suspicion. There are
strong association of PNS with certain malignancies, such
as limbic encephalitis and subacute cerebellar degenera-
tion. These syndromes are called classical PNS. [7] There
are other syndromes, such as sensorimotor polyneuropa-
thy may have some association with malignancies. [7]
It is believed that PNS is due to immunologic response to
ectopic antigen expressed in the tumor (onconeuroal anti-
gens) sharing the same antigens in the nervous system giv-
ing rise to cross reactivity to the antibodies produced by
the body. [5]
The importance in diagnosing PNS is at the time of PNS
symptoms, most patients would have no been diagnosed
with cancer, thus PNS can be used as a early diagnosing
tool [2] Antibodies have been used to detect PNS. These
antibodies are generally divided in to three groups, first
group belongs to well-characterized antibodies, are reac-
tive with molecularly defined onconeural antigens and
has a strongly association to cancer, second group is par-
tially characterized antibodies with an unidentified target
antigens which has been reported in few patients and the
third group consists of antibodies associated with specific
disorders but do no have the ability to differentiate
between paraneoplastic and nonparaneoplastic cases [7]
Lung cancer has been associated with various hematolog-
ical and laboratory abnormalities, some are part of PNS.
Small cell carcinoma has been reported to be associated
with marked hyperamylasemia [8] Our patient had per-
sistent hypercalcemia and leukocytosis. Both of these have
been associated with various malignancies, including
lung cancer as part of the PNS either independently or
very rarely together [9,10] The secretion of hematopoietic
growth factors like granulocyte-macrophage colony-stim-
ulating factor (GM-CSF), granulocyte-colony stimulating
factor (G-CSF), parathyroid hormone-related peptide,
interleukin (IL)-1, IL-6, and tumor necrosis factor (TNF)
are activated by squamous cell carcinoma cells and their
action on the common precursors of osteoclasts and gran-
Abdominal CT showing multiple low attenuation lesions with  a peripheral rim enhancement of varying sizes in the liver  suggestive of metastases or septic emboli Figure 3
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ulomonocytic cells simultaneously may attribute to the
presence of hypercalcemia-leukocytosis syndrome [11,12]
Hypercalcemia has been shown to be an ominous prog-
nostic sign in several malignancies [13,14] In lung cancer
patients, survival of patients with the hypercalcemia-leu-
kocytosis syndrome has been shown to be shorter than
that with hypercalcemia alone [15] The presence of this
hypercalcemia-leukocytosis syndrome could have been a
factor in the poor prognosis of our patient.
The goal of detection of PNS is for early diagnoses of the
malignancy and treatment of the tumor and the PNS. It
has been shown that anti-tumor therapy is effective
against tumor as well symptoms of PNS such as neurolog-
ical deterioration and give the patient on average better
symptom relief. [16]
Studies have shown despite the autoimmune etiology,
immunotherapy has been disappointing in the treatment
of PSN [16] Immunotherapy modalities currently recom-
mended are plasma exchange, immunoadsorption
(extraction of patient IgG over a protein A column), ster-
oids, and intravenous immunoglobin [17]
Conclusion
Lung cancer continues to present in advanced stages with
metastases at the time of diagnosis making the prognosis
poor. PNS associated with lung cancer if detected early can
prompt early detection, early treatment and better prog-
nosis. Unfortunately PNS is rarely seen and there should
be a high degree of suspicion to diagnose PNS. In patients
with PNS like in our patient the presence of leukocytosis-
hypercalcemia syndrome compounds the already poor
prognosis of advanced metastases.
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